Predict your next investment

HEALTHCARE | Drug Development

See what CB Insights has to offer


Merger | Merged

About Pear Tree Pharmaceuticals

Pear Tree Pharmaceuticals operates as a development stage pharmaceutical company which engages in the development and commercialization of pharmaceuticals for aging women. It offers products that treat and prevent diseases, symptoms, and conditions associated with menopause and cancer chemotherapy.

Pear Tree Pharmaceuticals Headquarter Location

125 Cambridge Park Drive

Cambridge, Massachusetts, 02140,

United States


Latest Pear Tree Pharmaceuticals News

Dare acquiring Pear Tree

May 21, 2018

Dare acquiring Pear Tree PDF Daré BioScience Inc. (NASDAQ:DARE) will acquire Pear Tree Pharmaceuticals Inc. (Cambridge, Mass. ), gaining its PT-101. The vaginal formulation of tamoxifen... Read the full 78 word article User Sign in Individual Use $30.00 USD What is BioCentury? BioCentury employs a fully integrated multimedia platform — including publications, video, online data solutions and conferences — to provide its audience with authoritative and up-to-date intelligence about corporate strategy, partnering, emerging technology, clinical data, public policy and the financial markets.

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Pear Tree Pharmaceuticals

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Pear Tree Pharmaceuticals is included in 2 Expert Collections, including Women's Health & Wellness.


Women's Health & Wellness

945 items

Startups focused on providing products and services catering to women's health and wellbeing.



4,844 items

Companies researching, developing, or offering products & services that aid in the screening, prevention, diagnosis, management, and treatment of cancer.

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.